| HOME >> MEDICINE >> TECHNOLOGY |
Regis Technologies, Inc. (USA) II-58
Shasun Pharmaceuticals Limited (India) II-59
Solvias (Switzerland) II-59
Sigma Aldrich Corp. (USA) II-59
Suven Life Sciences Ltd. (USA) II-59
14. GLOBAL MARKET PERSPECTIVE II-61
Table 3: World Recent Past, Current & Future Analysis for
Chiral Technology Enabling Products by Geographic Region - US,
Japan, Europe, and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2009 through 2017 (includes corresponding Graph/Chart) II-61
Table 4: World Historic Review for Chiral Technology Enabling
Products by Geographic Region - US, Japan, Europe, and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) II-62
Table 5: World 15-Year Perspective for Chiral Technology
Enabling Products by Geographic Region - Percentage Breakdown
of Value Sales for US, Japan, Europe, and Rest of World
Markets for Years 2003, 2011 & 2017 (includes corresponding
Graph/Chart) II-63
Table 6: World Recent Past, Current & Future Analysis for
Chiral Intermediates by Geographic Region - US, Japan, Europe,
and Rest of World Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) II-64
Table 7: World Historic Review for Chiral Intermediates by
Geographic Region - US, Japan, Europe, and Rest of World
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) II-65
Table 8: World 15-Year Perspective for Chiral Intermediates by
Geographic Region - Percentage
'/>"/>
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |